BioPharm International, March 2010 Issue (PDF)
Best Practices for Characterizing Formulation Design
India's Future as a Biologics Manufacturing Hub
Collaborations between Western and Indian companies may provide the best path for offshoring successfully and for developing India's readiness.
Downstream Processing: Promising Technologies are on the Horizon
The new technologies being developed to improve downstream systems go beyond traditional chromatography.
Corrective and Preventative Action Programs: A Mechanism of Control
An effective CAPA plan provides a mechanism for responding to the unexpected.
Characterizing the Formulation Design Space
Design of experiments is a valuable tool for identifying aspects of a formulation that are critical to product quality.
FDA Seeks More Timely Drug Information Electronically
The new Sentinel system aims to expand access to data on medical product safety and patient effects.
The Role of Process History in Establishing Clear Technology Transfer Criteria
Sufficient process history is key to the rapid transfer of your process.
Quality Considerations for Peptide Manufacturing Processes
As a key element in the peptide production process, quality should be built into every step.
Lessons from the War on Terrorism
Sharing information is a critical part of security-whether we're protecting travelers from bombs or patients from adulterated medicines.
Mathematical Programming for the Design and Analysis of a Biologics Facility-Part 2
An algorithmic approach to fine tune facility design and predict capacity.
